Go Deep
BeOne Medicines AG
BeOne Medicines AG Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 17,225 | 67.0 | 8.17 | 0.40 | 2,715.52 |
| Oct 2026 | 17,214 | 67.0 | 8.20 | 0.40 | 2,718.47 |
| Oct 2026 | 17,198 | 66.9 | 8.21 | 0.40 | 2,723.31 |
| Oct 2026 | 16,970 | 67.1 | 8.43 | 0.40 | 2,788.83 |
| Oct 2026 | 17,235 | 68.9 | 8.18 | 0.40 | 2,702.07 |
BeOne Medicines AG Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 1,705,071,000.0 | 1,513,438,000.0 | 1,498,170,000.0 | 1,412,284,000.0 |
| Net Profit | 237,007,000.0 | 227,357,000.0 | 66,502,000.0 | 124,841,000.0 |
| EPS | 0.2 | 0.2 | 0.1 | — |
BeOne Medicines AG Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 5,343,033,000.0 | 3,810,241,000.0 | 2,458,779,000.0 | 1,415,921,000.0 | — |
| Net Profit | 286,933,000.0 | -644,786,000.0 | -881,708,000.0 | -2,003,815,000.0 | — |
| EPS | 0.2 | -0.5 | -0.7 | -1.5 | — |
BeOne Medicines AG Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 8,188,573,000.0 | 5,920,910,000.0 | 5,805,275,000.0 | 6,379,290,000.0 | — |
| Total Liabilities | 3,827,379,000.0 | 2,588,688,000.0 | 2,267,948,000.0 | 1,995,935,000.0 | — |
| Total Equity | 4,361,194,000.0 | 3,332,222,000.0 | 3,537,327,000.0 | 4,383,355,000.0 | — |
Owes vs Owns
BeOne Medicines AG owed $0.44 for every $1 it owned in Jun 2026, up from $0.31 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.44× | 0.47× | 0.44× | 0.39× | 0.31× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
BeOne Medicines AG Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 55.5%Receivables 10.8%Inventory 7.4%Fixed assets (tangible) 21.0%Intangible assets 1.7%Long-term investments 0.8%Other assets 2.8%
How it's funded — Dec 2025
Short-term debt 0.7%Long-term debt 11.7%Payables 5.9%Other liabilities 28.4%Shareholders' equity 53.3%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 4,547.5 | 2,627.4 | 3,171.8 | 4,534.8 |
| Receivables | 886.9 | 709.1 | 395.9 | 199.0 |
| Inventory | 608.2 | 495.0 | 416.1 | 282.3 |
| Fixed assets (tangible) | 1,715.9 | 1,645.0 | 1,371.8 | 924.0 |
| Intangible assets | 141.6 | 129.8 | 108.9 | 94.6 |
| Long-term investments | 61.7 | 128.9 | 89.6 | 91.8 |
| Other assets | 226.7 | 185.7 | 251.2 | 252.8 |
| Liabilities & equity | ||||
| Short-term debt | 57.3 | 851.5 | 688.4 | 329.0 |
| Long-term debt | 961.9 | 166.5 | 197.6 | 209.1 |
| Payables | 479.0 | 405.0 | 315.1 | 294.8 |
| Other liabilities | 2,329.1 | 1,165.7 | 1,066.9 | 1,163.0 |
| Shareholders' equity | 4,361.2 | 3,332.2 | 3,537.3 | 4,383.4 |
| Net tangible assets | 4,219.6 | 3,202.5 | 3,428.5 | 4,288.8 |
BeOne Medicines AG Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 1,127,580,000.0 | -140,631,000.0 | -1,157,453,000.0 | -1,496,619,000.0 | — |
| Investing Activities | -276,155,000.0 | -548,350,000.0 | 60,004,000.0 | 1,077,123,000.0 | — |
| Financing Activities | 1,059,451,000.0 | 193,449,000.0 | 416,478,000.0 | -18,971,000.0 | — |